CytRx Corporation (NASDAQ:CYTR) will be unable to report data on overall survival, a secondary endpoint of its Phase 2b clinical trial of aldoxorubicin for soft tissue sarcoma (STS), when it presents results at the 2014 Connective Tissue Oncology Society (CTOS) Annual Meeting this week in Berlin, Germany. The biopharmaceutical company specializing in oncology said that due to the longer-than-expected survival of patients in the clinical trial, there have not been a sufficient number of survival events to enable reporting. The study will continue to track survival events and final results may be reported by the end of 2014 if the expected number of events occurs."Although it is too early to make any definitive assessment of the Phase 2b survival data, our early assessment is encouraging," said Sant P. Chawla, M.D., F.R.A.C.P., Director of the Sarcoma Oncology Center, and principal investigator of the trial. "As previously reported, aldoxorubicin has already demonstrated statistically significant improvements in progression-free survival, as well as promising improvements in tumor shrinkage and overall response rates." Shares of CytRx Corporation (NASDAQ:CYTR) are at $2.63 within a 52-week range of $2.00 - $8.35.Triumph Group Inc (NYSE:TGI) said it has acquired North American Aircraft Services, Inc., a leading provider of aviation maintenance, repair and overhaul services focused primarily on plane-side aircraft fuel systems. The acquired business will operate as Triumph Aviation Services - NAAS Division and be included in the Aftermarket Services Group. The business is expected to add approximately $35.0 million in annual revenue and to be immediately accretive to earnings. Based in San Antonio, Texas, NAAS delivers line maintenance services, ground support maintenance, routine and emergency fuel systems maintenance and repair, fuel leak detection and fuel bladder cell repair services. Triumph Group Inc (NYSE:TGI) trades in a 52-week range of $59.53 to $79.90.58.com Inc (ADR) (NYSE:WUBA) said it has agreed to invest $20 million to take a minority stake in Edaijia, a platform for mobile-based designated driver services in China. The Chinese online marketplace said the deal is expected to close in late October. "We plan to help them generate higher traffic from our site, a recognized brand, and share our management experience to help accelerate the growth of Edaijia," CEO Michael Yao said in a statement. "We expect the integration of Edaijia's service onto 58.com's platform will also enrich the experience for our own users." 58.com Inc (ADR) (NYSE:WUBA) closed higher 1.9% on Thursday, in the lower half of the 52-week range between $21.00 and $58.89.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
